XERS
#2235
Xeris Biopharma Holdings, Inc. - Common Stock
8.1 6 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.16%
Monthly Change
+20.18%
6 month change
+8.08%
Year Change
+49.45%
Previous Close
8.3 4
Open
8.1 6
Low
8.1 6
High
8.1 6
Volume
93
Financials
- Market Capitalization 1.41 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
4.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2185 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.41 USD | +0.25% | +9.14% | +8.28% | +113.49% | 1.50 B USD | ||
| 2204 |  NVAX Novavax, Inc. - Common Stock | 8.91 USD | -4.50% | -4.60% | -2.84% | +26.92% | 1.47 B USD | ||
| 2263 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 92.17 USD | -0.90% | -4.49% | +3.99% | +14.38% | 1.35 B USD | ||
| 2306 |  ARDX Ardelyx, Inc. - Common Stock | 5.14 USD | -2.65% | -4.10% | -10.45% | +11.02% | 1.27 B USD |
Frequently asked questions about Xeris Biopharma Holdings, Inc. - Common Stock
What is the Xeris Biopharma Holdings, Inc. - Common Stock stock price today?
The current price of Xeris Biopharma Holdings, Inc. - Common Stock (XERS) is 8.16. Over the past 24 hours, the stock has changed by -2.16%. Follow the XERS chart for real-time price dynamics.
What is the stock ticker of Xeris Biopharma Holdings, Inc. - Common Stock?
Xeris Biopharma Holdings, Inc. - Common Stock trades under the ticker XERS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Xeris Biopharma Holdings, Inc. - Common Stock stock going up?
XERS has changed by -3.09% over the last week, +20.18% over the last month, and +49.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Xeris Biopharma Holdings, Inc. - Common Stock net income for the last quarter?
Xeris Biopharma Holdings, Inc. - Common Stock reported net income of 11.08 M for the last quarter. The previous quarter showed 621 K, which means net income changed by +1684.38%.
How many employees does Xeris Biopharma Holdings, Inc. - Common Stock have?
As of the latest available data, Xeris Biopharma Holdings, Inc. - Common Stock has 435 employees. Workforce size can provide additional context about the company's scale and operations.
What is Xeris Biopharma Holdings, Inc. - Common Stock EBITDA?
Xeris Biopharma Holdings, Inc. - Common Stock EBITDA is -41.34 M, and its EBITDA margin is -48.18%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Xeris Biopharma Holdings, Inc. - Common Stock stock?
You can buy Xeris Biopharma Holdings, Inc. - Common Stock (XERS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Xeris Biopharma Holdings, Inc. - Common Stock stock?
Investing in Xeris Biopharma Holdings, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XERS chart and related analysis on metatrader.com as part of your research.